Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17461587 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL28642740 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL28644452 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL28633622 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL1128349 | 0.93 | TSHR (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL1469916 | 0.93 | TSHR (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL30179172 | 0.93 | TSHR (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL1471766 | 0.93 | TSHR (0.41) | ALDH1A1TSHRHSD17B10TP53HIF1A | |
| SCHEMBL47896 | 0.91 | SMN1; SMN2 (0.41) | ALDH1A1TSHRHSD17B10SMN1; SMN2ACHE | |
| SCHEMBL1470190 | 0.91 | ALDH1A1 (0.58) | ALDH1A1TSHRHSD17B10TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10658650-B2 | Secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20180241026-A1 | SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2018-08-23 | — | — | US | disclosed |
| US-9755273-B2 | Ion conducting fluoropolymer carbonates for alkali metal ion batteries | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2017-09-05 | — | — | US | disclosed |
| EP-2253710-B1 | PROCESS FOR PREPARING ASYMMETRICAL CARBONATE COMPOUNDS | UBE INDUSTRIES (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-8669375-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8318964-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2253710-A1 | ASYMMETRICAL CARBONATE COMPOUND AND MANUFACTURING METHOD THEREOF | Ube Industries, Ltd. (JP) | 2010-11-24 | — | — | EP | disclosed |
| EP-0972776-B1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | MITSUI CHEMICALS INC (JP) | 2003-04-23 | — | — | EP | disclosed |
| US-6153794-A | Phosphine sulfide, a manufacturing process therefor and use thereof | MITSUI CHEMICALS, INC. (JP) | 2000-11-28 | — | — | US | disclosed |
| CN-1262276-A | Phosphine sulfide preparing process and use thereof | MITSUI CHEMICALS INC (JP) | 2000-08-09 | — | — | CN | disclosed |
| EP-0972776-A1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | Mitsui Chemicals, Inc. (JP) | 2000-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | ALDH1A1 261/4885TSHR 2444/4885HSD17B10 47/4885 |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | ALDH1A1 252/4885TSHR 2452/4885HSD17B10 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.